Mark E. Lobatto

27 papers receiving 2.6k citations

Peers

Mark E. Lobatto
Comparison fields: 5 of 88
  • Biomaterials 1.2k
  • Drug Discovery 13
  • Immunology 684
  • Radiology, Nuclear Medicine and Imaging 440
  • Biomedical Engineering 472
Replace François Fay with:
François Fay United States
Sarayu Ramachandran United States
Ewelina Kluza Netherlands
Elizabeth D. Hood United States
Max L. Senders United States
Alexandros Marios Sofias Germany
Smriti Singh Germany
Xiaoxue Xie China
Rivka Cohen Israel
Bram Priem Netherlands
Mark E. Lobatto relative to François Fay United States François Fay's profile →
Citations per field
00.5×1.5×
François Fay · 1×
Citations per year

Countries citing papers authored by Mark E. Lobatto

Since Specialization
Citations

This map shows the geographic impact of Mark E. Lobatto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Lobatto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Lobatto more than expected).

Fields of papers citing papers by Mark E. Lobatto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Lobatto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Lobatto. The network helps show where Mark E. Lobatto may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Lobatto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Lobatto Line = papers co-authored together Mark E. Lobatto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014395
2 2011362
3 2008287
4 2015201
5 2014170
6 2010145
7 2015144
8 2015143
9 2015111
10 201490
11 201689
12 201882
13 201180
14 201964
15 201145
16 200844
17 201843
18 201541
19 202037
20 201535

About Mark E. Lobatto

Mark E. Lobatto is a scholar working on Biomaterials, Immunology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Biomedical Engineering, having authored 28 papers that have together received 2.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Atherosclerosis and Cardiovascular Diseases (11 papers), Cardiac Imaging and Diagnostics (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Nanoplatforms for cancer theranostics (3 papers), Cholesterol and Lipid Metabolism (2 papers), COVID-19 Clinical Research Studies (2 papers) and Advanced MRI Techniques and Applications (2 papers). The work is most often cited by research in Biomaterials (1.2k citations), Drug Discovery (13 citations), Immunology (684 citations), Radiology, Nuclear Medicine and Imaging (440 citations) and Biomedical Engineering (472 citations). Mark E. Lobatto has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Willem J. M. Mulder, Zahi Adel Fayad, Valentı́n Fuster, Claudia Calcagno, Edward A A Fisher, Erik S. G. Stroes, Ronald E. Gordon, Gerrit Storm, David P. Cormode and François Fay. Their work appears in journals such as Journal of the American College of Cardiology, Bioconjugate Chemistry, Annals of Surgery, JACC. Cardiovascular imaging and Nanomedicine Nanotechnology Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact